METHOD FOR DETERMINING INDICATIONS TO INTRA-ARTICULAR ADMINISTRATION OF CHONDROPROTECTOR AGENTS BASED ON CARTILAGE GLYCOSOAMINES HYDROLYSATE Russian patent published in 2003 - IPC

FIELD: medicine. SUBSTANCE: method involves adding chondroprotector agent based on cartilage glycosoamine hydrolysate to Bacto-Agar Typ USA solution and mixing. The solution is poured over glass plate and gel layer is produced. Synovial fluid is dropped into holes after having perforated the gel layer and hold in crystallizer. Coloring taking place, precipitate rings are identified. Rings availability indicates contraindications to intra-articular administration of chondroprotector agents based on cartilage glycosoamine hydrolysate. EFFECT: high accuracy in predicting in vitro autoimmune process development; avoided hypersensitivity phenomena. 1 dwg